These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28508557)

  • 1. LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.
    Brown PM; Tzannes S; Nguyen S; White J; Langova V
    Vet Comp Oncol; 2018 Mar; 16(1):108-113. PubMed ID: 28508557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
    Morgan E; O'Connell K; Thomson M; Griffin A
    Vet Comp Oncol; 2018 Dec; 16(4):622-629. PubMed ID: 30117253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
    Blaxill J; Buzzacott P; Finlay J
    Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
    Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
    Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
    Fahey CE; Milner RJ; Barabas K; Lurie D; Kow K; Parfitt S; Lyles S; Clemente M
    J Am Vet Med Assoc; 2011 Jul; 239(2):209-15. PubMed ID: 21756176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
    Rassnick KM; Bailey DB; Malone EK; Intile JL; Kiselow MA; Flory AB; Barlow LL; Balkman CE; Barnard SM; Waite AH
    Vet Comp Oncol; 2010 Dec; 8(4):243-53. PubMed ID: 21062406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs.
    Back AR; Schleis SE; Smrkovski OA; Lee J; Smith AN; Phillips JC
    Vet Comp Oncol; 2015 Dec; 13(4):398-408. PubMed ID: 23910023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHOP chemotherapy for the treatment of canine multicentric T-cell lymphoma.
    Rebhun RB; Kent MS; Borrofka SA; Frazier S; Skorupski K; Rodriguez CO
    Vet Comp Oncol; 2011 Mar; 9(1):38-44. PubMed ID: 21303452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Study of Multi-agent Chemotherapy including either Cyclophosphamide or Lomustine as Initial Therapy for Canine High-grade T-cell Lymphoma (2011-2017).
    Elliott J; Baines S
    Aust Vet J; 2019 Sep; 97(9):308-315. PubMed ID: 31328256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asparaginase and MOPP treatment of dogs with lymphoma.
    Brodsky EM; Maudlin GN; Lachowicz JL; Post GS
    J Vet Intern Med; 2009; 23(3):578-84. PubMed ID: 19645842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma.
    Parker AS; Burton JH; Curran KM; Wolf-Ringwall A; Thamm DH
    J Vet Intern Med; 2024; 38(4):2282-2292. PubMed ID: 38961691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.
    Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB
    J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).
    Rassnick KM; Mauldin GE; Al-Sarraf R; Mauldin GN; Moore AS; Mooney SC
    J Vet Intern Med; 2002; 16(5):576-80. PubMed ID: 12322709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF; Thamm DH; Vail DM
    J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and toxicity of BOPP and LOPP chemotherapy for the treatment of relapsed canine lymphoma.
    LeBlanc AK; Mauldin GE; Milner RJ; LaDue TA; Mauldin GN; Bartges JW
    Vet Comp Oncol; 2006 Mar; 4(1):21-32. PubMed ID: 19754826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of canine non-indolent T cell lymphoma using the VELCAP-TSC protocol: A retrospective evaluation of 70 dogs (2003-2013).
    Goodman IH; Moore AS; Frimberger AE
    Vet J; 2016 May; 211():39-44. PubMed ID: 27017053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma.
    Saba CF; Hafeman SD; Vail DM; Thamm DH
    J Vet Intern Med; 2009; 23(5):1058-63. PubMed ID: 19678892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Lomustine and Prednisolone as First-Line Treatment in Canine Multicentric Lymphoma.
    Catalucci C; Bianchi ML; Treggiari E; Pieri M; Ruess K; Valenti P
    Vet Comp Oncol; 2024 Sep; 22(3):422-428. PubMed ID: 38890811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
    Koza I; Bohunický L; Mociková K; Gyárfás J; Svancárová L; Mardiak J; Spánik S; Fuchsberger P; Thalmeinerová Z; Sufliarsky J
    Neoplasma; 1991; 38(6):583-93. PubMed ID: 1722564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trial.
    Hancock BW; Vaughan Hudson G; Vaughan Hudson B; Bennett MH; MacLennan KA; Haybittle JL; Anderson L; Linch DC
    J Clin Oncol; 1992 Aug; 10(8):1252-8. PubMed ID: 1634914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.